{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:08:44Z","timestamp":1790968124503,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T00:00:00Z","timestamp":1349913600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/bjc.2012.462","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T22:47:56Z","timestamp":1349995676000},"page":"1810-1814","source":"Crossref","is-referenced-by-count":138,"title":["Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000\u20132009"],"prefix":"10.1038","volume":"107","author":[{"given":"A","family":"Sita-Lumsden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N J","family":"Sebire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Adjogatse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Seckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P M","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,11]]},"reference":[{"key":"BFbjc2012462_CR1","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1200\/JCO.2010.31.0151","volume":"29","author":"C Aghajanian","year":"2011","unstructured":"Aghajanian C (2011) Treatment of low-risk gestational trophoblastic neoplasia. J Clin Oncol 29: 786\u2013788","journal-title":"J Clin Oncol"},{"key":"BFbjc2012462_CR2","doi-asserted-by":"crossref","unstructured":"Alazzam M, Tidy J, Hancock BW, Osborne R (2009) First line chemotherapy in low risk gestational trophoblastic neoplasia. Cochrane Database Syst Rev 1: (CD007102)","DOI":"10.1002\/14651858.CD007102.pub2"},{"key":"BFbjc2012462_CR3","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.1997.15.7.2636","volume":"15","author":"M Bower","year":"1997","unstructured":"Bower M, Newlands ES, Holden L, Short D, Brock C, Rustin GJ, Begent RH, Bagshawe KD (1997) EMA\/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 15: 2636\u20132643","journal-title":"J Clin Oncol"},{"key":"BFbjc2012462_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0959-8049(98)00059-8","volume":"34","author":"M Bower","year":"1998","unstructured":"Bower M, Rustin GJ, Newlands ES, Holden L, Short D, Foskett M, Bagshawe KD (1998) Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. Eur J Cancer 34: 1204\u20131207","journal-title":"Eur J Cancer"},{"key":"BFbjc2012462_CR5","doi-asserted-by":"publisher","first-page":"643.e1","DOI":"10.1016\/j.ajog.2009.03.011","volume":"200","author":"GE Chalouhi","year":"2009","unstructured":"Chalouhi GE, Golfier F, Soignon P, Massardier J, Guastalla JP, Trillet-Lenoir V, Schott AM, Raudrant D (2009) Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity. Am J Obstet Gynecol 200: 643.e1\u2013643.e6","journal-title":"Am J Obstet Gynecol"},{"key":"BFbjc2012462_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ygyno.2009.02.006","volume":"113","author":"LM El-Helw","year":"2009","unstructured":"El-Helw LM, Coleman RE, Everard JE, Tidy JA, Horsman JM, Elkhenini HF, Hancock BW (2009) Impact of the revised FIGO\/WHO system on the management of patients with gestational trophoblastic neoplasia. Gynecol Oncol 113: 306\u2013311","journal-title":"Gynecol Oncol"},{"key":"BFbjc2012462_CR7","first-page":"253","volume":"55","author":"V F\u00fcl\u00f6p","year":"2010","unstructured":"F\u00fcl\u00f6p V, Szigetv\u00e1ri I, Szepesi J, V\u00e9gh G, B\u00e1torfi J, Nagym\u00e1nyoki Z, T\u00f6r\u00f6k M, Berkowitz RS (2010) 30 years\u2019 experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary. J Reprod Med 55: 253\u2013257","journal-title":"J Reprod Med"},{"key":"BFbjc2012462_CR8","first-page":"279","volume":"55","author":"WB Growdon","year":"2010","unstructured":"Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES, Berkowitz RS (2010) Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy. J Reprod Med 55: 279\u2013284","journal-title":"J Reprod Med"},{"key":"BFbjc2012462_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3181\/00379727-93-22757","volume":"93","author":"R Hertz","year":"1956","unstructured":"Hertz R, Li MC, Spencer DB (1956) Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med 93: 361\u2013366","journal-title":"Proc Soc Exp Biol Med"},{"key":"BFbjc2012462_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/AOG.0b013e31817f58ae","volume":"112","author":"AV Hoekstra","year":"2008","unstructured":"Hoekstra AV, Lurain JR, Rademaker AW, Schink JC (2008) Gestational trophoblastic neoplasia: treatment outcomes. Obstet Gynecol 112: 251\u2013258","journal-title":"Obstet Gynecol"},{"key":"BFbjc2012462_CR11","first-page":"185","volume":"39","author":"HD Homesley","year":"1994","unstructured":"Homesley HD (1994) Development of single-agent chemotherapy regimens for gestational trophoblastic disease. J Reprod Med 39: 185\u2013192","journal-title":"J Reprod Med"},{"key":"BFbjc2012462_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ygyno.2010.02.029","volume":"117","author":"WD Kang","year":"2010","unstructured":"Kang WD, Choi HS, Kim SM (2010) Weekly methotrexate (50\u2009mg\/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia. Gynecol Oncol 117: 477\u2013480","journal-title":"Gynecol Oncol"},{"key":"BFbjc2012462_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/IGC.0b013e3181a8333d","volume":"19","author":"AA Lertkhachonsuk","year":"2009","unstructured":"Lertkhachonsuk AA, Israngura N, Wilailak S, Tangtrakul S (2009) Actinomycin d versus methotrexate-folinic acid as the treatment of stage I, low-risk gestational trophoblastic neoplasia: a randomized controlled trial. Int J Gynecol Cancer 19: 985\u2013988","journal-title":"Int J Gynecol Cancer"},{"key":"BFbjc2012462_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/sj.bjc.6605529","volume":"102","author":"S McGrath","year":"2010","unstructured":"McGrath S, Short D, Harvey R, Schmid P, Savage PM, Seckl MJ (2010) The management and outcome of women with post-hydatidiform mole \u2018low-risk\u2019 gestational trophoblastic neoplasia, but hCG levels in excess of 100\u2009000 IU l(-1). Br J Cancer 102: 810\u2013814","journal-title":"Br J Cancer"},{"key":"BFbjc2012462_CR15","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1200\/JCO.2002.07.166","volume":"20","author":"IA McNeish","year":"2002","unstructured":"McNeish IA, Strickland S, Holden L, Rustin GJ, Foskett M, Seckl MJ, Newlands ES (2002) Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 20: 1838\u20131844","journal-title":"J Clin Oncol"},{"issue":"S1","key":"BFbjc2012462_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0020-7292(03)90120-2","volume":"83","author":"HY Ngan","year":"2003","unstructured":"Ngan HY, Bender H, Benedet JL, Jones H, Montruccoli GC, Pecorelli S (2003) Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet 83 (S1): 175\u2013177","journal-title":"Int J Gynaecol Obstet"},{"key":"BFbjc2012462_CR17","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1200\/JCO.1996.14.10.2769","volume":"14","author":"GJ Rustin","year":"1996","unstructured":"Rustin GJ, Newlands ES, Lutz JM, Holden L, Bagshawe KD, Hiscox JG, Foskett M, Fuller S, Short D (1996) Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol 14: 2769\u20132773","journal-title":"J Clin Oncol"},{"key":"BFbjc2012462_CR18","first-page":"774","volume":"53","author":"P Savage","year":"2008","unstructured":"Savage P, Seckl M, Short D (2008) Practical issues in the management of low-risk gestational trophoblast tumors. J Reprod Med 53: 774\u2013780","journal-title":"J Reprod Med"},{"key":"BFbjc2012462_CR19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","volume":"376","author":"MJ Seckl","year":"2010","unstructured":"Seckl MJ, Sebire NJ, Berkowitz RS (2010) Gestational trophoblastic disease. Lancet 376: 717\u2013729","journal-title":"Lancet"},{"key":"BFbjc2012462_CR20","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/annonc\/mdn181","volume":"19","author":"J Wang","year":"2008","unstructured":"Wang J, Short D, Sebire NJ, Lindsay I, Newlands ES, Schmid P, Savage PM, Seckl MJ (2008) Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel\/cisplatin alternating with paclitaxel\/etoposide (TP\/TE). Ann Oncol 19: 1578\u20131583","journal-title":"Ann Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2012462.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012462","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012462.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:11:24Z","timestamp":1684415484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2012462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["BFbjc2012462"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.462","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,11]]}}}